Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients

Transplantation

Volumn 83, Issue 5, 2007, Pages 649-652

  Serón, Daniel ^a   O'Valle, Francisco ^b   Moreso, Francesc ^a   Gomà, Montse ^a   Hueso, Miguel ^a   Grinyó, Josep M ^a   Del Moral, Raimundo Garcia ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Cyclosporine; Immunophenotype; Subclinical rejection; Tacrolimus

Indexed keywords

BASILIXIMAB; CD20 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CYCLOSPORIN; DACLIZUMAB; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOPHENOTYPING; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; LEUKOCYTE; LEYDIG CELL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIGENS, CD; BIOPSY; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33947315099     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000253760.35580.d3     Document Type: Article

References (24)

1. Nankivell BJ, Borrows RJ, Fung CLS, et al. The natural history of chronic allograft nephropathy. N Eng J Med 2003; 349: 2326.
2. Nankivell BJ, Borrows RJ, Fung CLS, et al. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004; 78: 242.
3. Choi BS, Shin MJ, Sjin SJ, et al. Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center. Am J Transplant 2005; 5: 1354.
4. Shishido S, Asanuma H, Nakai H, et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003; 14: 1046.
5. Cosio FG, Grande JP, Wadei H, et al. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005; 5: 2464.
6. Moreso F, Ibernon M, Goma M, et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6: 747.
7. Rush DN, Nickerson P, Gough J, et al. Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol 1998; 9: 2129.
8. Moreso F, Seron D, Carrera M, et al. Baseline inmunosuppression is associated with histological findings in early protocol biopsies. Transplantation 2004; 78: 1064.
9. Rowshani AT, Scholten EM, Nenelman F, et al. No difference in degree of interstitial Sirius Red-Stained area in serial protocol biopsies from area under concentration-over-time curves guided cyclosporine versus tacrolimus treated renal transplant recipients at one year. J Am Soc Nephrol 2006; 17: 305.
10. Mizuiri S, Iwamoto M, Miyagi M, et al. Activation of nuclear factor-kappa B and macrophage invasion in cyclosporine A and tacrolimus-treated renal transplants. Clin Transplant 2004; 18: 14.
11. Raftery MJ, Seron D, Koffman G, et al. The relevance of induced class II HLA antigens and macrophage infiltration in early renal allograft biopsies. Transplantation 1989; 48: 238.
12. Yehia M, Matheson PJ, Merrilees MJ, et al. Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques. Nephrology 2006; 11: 261.
13. Palomar R, Ruiz JC, Mayorga M, et al. The macrophage infiltration index and matrix metaloproteinase-II expression as a predictor of chronic allograft rejection. Transplant Proc 2004; 36: 2662.
14. Wieczorek G, Bigaud M, Menninger K, et al. Acute and chronic vascular rejection in non human primate kidney transplantation. Am J Transplant 2006; 6: 1285.
15. Seron D, Diaz-Gallo C, Grino JM, et al. Characterization of interstitial infiltrate in early renal allograft biopsies in patients with stable renal function. Transplant Proc 1991; 23: 1267.
16. Matsue H, Yang C, Matsue K, et al. Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporine A and dexametasone) on bidirectional dentritic cell-T cell interaction during antigen presentation. J Immunol 2002; 169: 3555.
17. Pascual M, Saidman S, Tolkoff-Rubin N, et al. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation 1998; 66: 1460.
18. Sun Q, Liu ZH, Yin G, et al. Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d positive steroid-resistant acute rejection in Chinese renal allograft recipients. Nephrol Dial Transplant 2006; 21: 510.
19. Theruvath TP, Saidman SL, Mauiyyedi S, et al. Control of antidonor production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation 2001; 72: 77.
20. Hippen BE, DeMattos A, Cook WJ, et al. Association of CD20-+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant 2005; 5: 2248.
21. Kee TYS, Chapman JR, O'Conell PJ, et al. Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. Transplantation 2006; 82: 36.
22. Solez K, Vincenti F, Filo RS. Histological findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation 1998; 66: 1736.
23. Magil AB, Tinckam K. Monocyte and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003; 63: 1888.
24. Tinckam KJ, Djurdjev O, Magil AB. Glomerular monocytes predict worse outcome after acute renal allograft rejection independent of C4d status. Kidney Int 2005; 68: 1866.